These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 23382745)
1. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745 [TBL] [Abstract][Full Text] [Related]
2. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria. Ogwu-Richard SO; Ojo DA; Akingbade OA; Okonko IO Afr Health Sci; 2015 Sep; 15(3):719-27. PubMed ID: 26957958 [TBL] [Abstract][Full Text] [Related]
3. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015). Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria. Nnakenyi ID; Uchechukwu C; Nto-Ezimah U Afr Health Sci; 2020 Jun; 20(2):579-586. PubMed ID: 33163019 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola. Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda. Baseke J; Musenero M; Mayanja-Kizza H Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775 [TBL] [Abstract][Full Text] [Related]
8. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria. Adekunle AE; Oladimeji AA; Temi AP; Adeseye AI; Akinyeye OA; Taiwo RH Pan Afr Med J; 2011; 9():6. PubMed ID: 22145054 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434 [TBL] [Abstract][Full Text] [Related]
10. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria. Opaleye OO; Igboama MC; Ojo JA; Odewale G J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal. Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874 [TBL] [Abstract][Full Text] [Related]
13. Serological markers and risk factors for hepatitis B and hepatitis C viruses among students in a Nigerian university. Forbi J; Pennap G; Silas-Ndukuba C; Agabi Y; Agwale S East Afr J Public Health; 2009 Aug; 6(2):152-5. PubMed ID: 20000021 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. Muriuki BM; Gicheru MM; Wachira D; Nyamache AK; Khamadi SA BMC Res Notes; 2013 Sep; 6():363. PubMed ID: 24016453 [TBL] [Abstract][Full Text] [Related]
15. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Jobarteh M; Malfroy M; Peterson I; Jeng A; Sarge-Njie R; Alabi A; Peterson K; Cotten M; Hall A; Rowland-Jones S; Whittle H; Tedder R; Jaye A; Mendy M Virol J; 2010 Sep; 7():230. PubMed ID: 20843322 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study. Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842 [TBL] [Abstract][Full Text] [Related]
18. Sexual behaviors and seroprevalence of HIV, HBV, and HCV among hill tribe youths of Northern Thailand. Apidechkul T BMC Public Health; 2019 Aug; 19(1):1101. PubMed ID: 31412838 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia. Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947 [TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study. Ionita G; Malviya A; Rajbhandari R; Schluter WW; Sharma G; Kakchapati S; Rijal S; Dixit S Int J Infect Dis; 2017 Jul; 60():64-69. PubMed ID: 28483724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]